Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;36(1):525-542.
doi: 10.1002/ptr.7337. Epub 2021 Nov 30.

Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis

Affiliations

Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis

Linlin Wang et al. Phytother Res. 2022 Jan.

Abstract

Alnustone, a diarylheptane compound, exhibits potent growth inhibition against hepatocellular carcinoma (HCC) BEL-7402 cells. However, the underlying mechanisms associated with its anticancer activity remain unknown. In the present study, we evaluated the anticancer effect of alnustone against several human cancers focused on HCC and the possible associated mechanisms. The results showed that alnustone significantly inhibited the growth of several cancer cells by CCK-8 assay. Alnustone markedly induced apoptosis and decreased mitochondrial membrane potential in BEL-7402 and HepG2 cells. Alnustone inhibited the expression of proteins related to apoptosis and PI3K/Akt/mTOR/p70S6K pathways and generated ROS production in BEL-7402 and HepG2 cells. Moreover, N-acetyl-L-cysteine (NAC, a ROS inhibitor) could significantly reverse the effects of alnustone on the growth inhibition of BEL-7402 and HepG2 cells and the expression of proteins related to apoptosis and PI3K/Akt/mTOR signaling pathway in HepG2 cells. Furthermore, alnustone significantly inhibited tumor growth of HepG2 xenografts, obviously induced apoptosis in the tumor tissues and improved the pathological condition of liver tissues of mice in vivo. The study provides evidence that alnustone is effective against HCC via ROS-mediated PI3K/Akt/mTOR/p70S6K pathway and the compound has the potential to be developed as a novel anticancer agent for the treatment of HCC clinically.

Keywords: PI3K/Akt/mTOR/p70S6K signaling pathway; alnustone; human hepatocellular carcinoma; reactive oxygen species.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. An, W., Lai, H., Zhang, Y., Liu, M., Lin, X., & Cao, S. (2019). Apoptotic pathway as the therapeutic target for anticancer traditional Chinese medicines. Frontiers in Pharmacology, 10, 758. https://doi.org/10.3389/fphar.2019.00758
    1. Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018). Kinase-targeted cancer therapies: Progress, challenges and future directions. Molecular Cancer, 17(1), 48. https://doi.org/10.1186/s12943-018-0804-2
    1. Bray, F., Ferlay, J., Soerjomataram, I., Torre, L. A., Siegel, R. L., & Jemal, A. (2018). Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 392-424. https://doi.org/10.3322/caac.21492
    1. Cao, S., McGuire, J. J., & Rustum, Y. M. (1999). Antitumor activity of ZD1694 against human head and neck cancer in nude mice models: Role of dosing schedule and plasma thymidine. Clinical Cancer Research, 5(7), 1925-1934.
    1. Cheng, H., Jiang, X., Zhang, Q., Ma, J., Cheng, R., Yong, H., … Gao, G. (2020). Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway. Experimental and Therapeutic Medicine, 19(6), 3798-3804.

MeSH terms

Substances

LinkOut - more resources